Extranodal NK/T Cell Lymphoma, Nasal Type
The extended involved site radiation therapy (ISRT) is incorporated into the treatment of patients with stage I and contiguous stage II extranodal natural killer/T cell lymphoma. It is suggested combined modality therapy with radiation and chemotherapy. The extended ISRT should be given concurrently with chemotherapy, but if the patient’s performance status and comorbidities do not allow concurrent therapy, radiation should be administered prior to chemotherapy.
KeywordsNasal cavity Extranodal natural killer/T cell lymphoma Nasal type Extended involved site radiation therapy (extended ISRT) Epstein-Barr virus (EBV)
- 1.Swerdlow SH, Campo E, Harris NL, editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.Google Scholar
- 12.Kim SJ, Kim K, Kim BS, et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol. 2009;27:6027.CrossRefPubMedGoogle Scholar